- Home
- COLL vs SVM Comparison
COLL vs SVM Comparison
Compare COLL & SVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- SVM
- Stock Information
- Founded
- COLL 2002
- SVM N/A
- Country
- COLL United States
- SVM Canada
- Employees
- COLL N/A
- SVM N/A
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- SVM Precious Metals
- Sector
- COLL Health Care
- SVM Basic Materials
- Exchange
- COLL Nasdaq
- SVM Nasdaq
- Market Cap
- COLL 910.2M
- SVM 769.7M
- IPO Year
- COLL 2015
- SVM N/A
- Fundamental
- Price
- COLL $29.71
- SVM $3.88
- Analyst Decision
- COLL Strong Buy
- SVM Strong Buy
- Analyst Count
- COLL 5
- SVM 1
- Target Price
- COLL $43.60
- SVM $5.10
- AVG Volume (30 Days)
- COLL 466.9K
- SVM 6.2M
- Earning Date
- COLL 05-08-2025
- SVM 05-22-2025
- Dividend Yield
- COLL N/A
- SVM 0.64%
- EPS Growth
- COLL 43.56
- SVM 104.66
- EPS
- COLL 1.86
- SVM 0.36
- Revenue
- COLL $631,449,000.00
- SVM $266,463,000.00
- Revenue This Year
- COLL $19.43
- SVM $35.71
- Revenue Next Year
- COLL $3.34
- SVM $10.92
- P/E Ratio
- COLL $16.00
- SVM $10.81
- Revenue Growth
- COLL 11.41
- SVM 28.94
- 52 Week Low
- COLL $27.28
- SVM $2.87
- 52 Week High
- COLL $42.29
- SVM $5.32
- Technical
- Relative Strength Index (RSI)
- COLL 48.90
- SVM 50.54
- Support Level
- COLL $29.33
- SVM $3.93
- Resistance Level
- COLL $30.84
- SVM $4.22
- Average True Range (ATR)
- COLL 0.85
- SVM 0.17
- MACD
- COLL 0.08
- SVM -0.03
- Stochastic Oscillator
- COLL 50.11
- SVM 31.75
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About SVM Silvercorp Metals Inc.
Silvercorp Metals Inc is a mineral mining company. It acquires, explores, develops, and mines precious and base metal mineral properties at its producing mines and exploration and development projects in China. The group produces silver, gold, lead, and zinc. The company creates shareholder's value by focusing on generating free cash flow from long-life mines; organic growth through extensive drilling for discovery; equity investments in potential world-class opportunities; ongoing merger and acquisition efforts to unlock value; and long-term commitment to responsible mining and ESG. The Company's producing mines are located in China, and current exploration and development projects are located in China and Mexico.